COMPANY PROFILE · /xaira-therapeutics
X
Xaira Therapeutics
Xaira Therapeutics is an AI-driven drug discovery platform using protein design diffusion models and generative chemistry to engineer novel therapeutics. Founded by Nobel laureate David Baker and computational biology experts, it raised $1B in Series A funding—one of the largest healthcare venture rounds ever.
Fresh · 5d ago
Latest valuation
—
Annual Recurring Revenue
—
Headcount
—
Funding total
$1B
OVERVIEW
Emerged Q2 2024 with $1B—largest initial commitment in Arch Venture's 39-year history. Board includes Nobel laureates, former FDA commissioners, and pharma execs. Building antibody therapeutics and target discovery pipeline.
Status
active
Tier
master-list
Profitability
—
Pricing
enterprise
FUNDING HISTORY · 0
No funding rounds on file.
PRODUCTS · 0
No products catalogued yet. Press Refresh above to ask the research agent.
TEAM · 0 key people
No people linked.
SOURCES · 0 cited
No citations stored yet. Run the research agent to attach per-claim sources.